Carl Zeiss Meditec AG (AFX.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap3.69B
Enterprise Value4.27B
P/E Ratio23.06
PEG Ratio-0.98
Price/Sales Ratio1.04
Price/Book Ratio1.31
Enterprise/Revenue1.27
Enterprise/EBITDA11.02

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.03
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue2.23B
Revenue/Share30.1
Gross Profit1.18B
EBITDA346.89M
Net Income141.21M
Diluted EPS1.61

Balance Sheet

Total Cash23.9M
Total Cash/Share0.27
Total Debt617.55M
Total Debt/Equity0.29
Current Ratio2.43
Book Value Per Share24.08

Price History

52-Week Change-39.28
52-Week High53.1
52-Week Low22.62
Moving Average 50 Days26.51
Moving Average 200 Days32.63

Statistics

Average Volume221,983
Shares Outstanding87.54M
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate0.55
Trailing Annual Dividend Yield1.75
Payout Ratio0.54
Last Split Factor1369:1000
Last Split DateOctober 24, 2006
AD